Cargando…

Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging

Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Triest, Filip J. J., Franssen, Frits M. E., Reynaert, Niki, Gaffron, Swetlana, Spruit, Martijn A., Janssen, Daisy J. A., Rutten, Erica P. A., Wouters, Emiel F. M., Vanfleteren, Lowie E. G. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517869/
https://www.ncbi.nlm.nih.gov/pubmed/31013986
http://dx.doi.org/10.3390/jcm8040511
_version_ 1783418340533862400
author Triest, Filip J. J.
Franssen, Frits M. E.
Reynaert, Niki
Gaffron, Swetlana
Spruit, Martijn A.
Janssen, Daisy J. A.
Rutten, Erica P. A.
Wouters, Emiel F. M.
Vanfleteren, Lowie E. G. W.
author_facet Triest, Filip J. J.
Franssen, Frits M. E.
Reynaert, Niki
Gaffron, Swetlana
Spruit, Martijn A.
Janssen, Daisy J. A.
Rutten, Erica P. A.
Wouters, Emiel F. M.
Vanfleteren, Lowie E. G. W.
author_sort Triest, Filip J. J.
collection PubMed
description Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a biomarker of accelerated aging as a potential mechanistic factor. Methods: Body composition, metabolic, cardiovascular, musculoskeletal, and psychological morbidities were objectively evaluated in 208 COPD patients (age 62 ± 7 years, 58% males, FEV(1) 50 ± 16% predicted) and 200 non-COPD controls (age 61 ± 7 years, 45% males). Based on their presence and severity, the morbidities were clustered to generate distinct clusters in COPD and controls. Telomere length in circulating leukocytes was compared across the clusters. Results: (co)morbidities were more prevalent in COPD patients compared to controls (3.9 ± 1.7 vs. 2.4 ± 1.5, p < 0.05). A “Psychologic” and “Cachectic” cluster were only present in the COPD population. “Less (co)morbidity”, “Cardiovascular”, and “Metabolic” clusters were also observed in controls, although with less complexity. Telomere length was reduced in COPD patients, but did not differ between the (co)morbidity clusters in both populations. Conclusions: Two COPD-specific comorbidity clusters, a “Cachectic” and “Psychologic” cluster, were identified and warrant further studies regarding their development. Accelerated aging was present across various multimorbidity clusters in COPD.
format Online
Article
Text
id pubmed-6517869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65178692019-05-31 Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging Triest, Filip J. J. Franssen, Frits M. E. Reynaert, Niki Gaffron, Swetlana Spruit, Martijn A. Janssen, Daisy J. A. Rutten, Erica P. A. Wouters, Emiel F. M. Vanfleteren, Lowie E. G. W. J Clin Med Article Background: Patients with chronic obstructive pulmonary disease (COPD) often suffer from multiple morbidities, which occur in clusters and are sometimes related to accelerated aging. This study aimed to assess the disease specificity of comorbidity clusters in COPD and their association with a biomarker of accelerated aging as a potential mechanistic factor. Methods: Body composition, metabolic, cardiovascular, musculoskeletal, and psychological morbidities were objectively evaluated in 208 COPD patients (age 62 ± 7 years, 58% males, FEV(1) 50 ± 16% predicted) and 200 non-COPD controls (age 61 ± 7 years, 45% males). Based on their presence and severity, the morbidities were clustered to generate distinct clusters in COPD and controls. Telomere length in circulating leukocytes was compared across the clusters. Results: (co)morbidities were more prevalent in COPD patients compared to controls (3.9 ± 1.7 vs. 2.4 ± 1.5, p < 0.05). A “Psychologic” and “Cachectic” cluster were only present in the COPD population. “Less (co)morbidity”, “Cardiovascular”, and “Metabolic” clusters were also observed in controls, although with less complexity. Telomere length was reduced in COPD patients, but did not differ between the (co)morbidity clusters in both populations. Conclusions: Two COPD-specific comorbidity clusters, a “Cachectic” and “Psychologic” cluster, were identified and warrant further studies regarding their development. Accelerated aging was present across various multimorbidity clusters in COPD. MDPI 2019-04-14 /pmc/articles/PMC6517869/ /pubmed/31013986 http://dx.doi.org/10.3390/jcm8040511 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Triest, Filip J. J.
Franssen, Frits M. E.
Reynaert, Niki
Gaffron, Swetlana
Spruit, Martijn A.
Janssen, Daisy J. A.
Rutten, Erica P. A.
Wouters, Emiel F. M.
Vanfleteren, Lowie E. G. W.
Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title_full Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title_fullStr Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title_full_unstemmed Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title_short Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
title_sort disease-specific comorbidity clusters in copd and accelerated aging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517869/
https://www.ncbi.nlm.nih.gov/pubmed/31013986
http://dx.doi.org/10.3390/jcm8040511
work_keys_str_mv AT triestfilipjj diseasespecificcomorbidityclustersincopdandacceleratedaging
AT franssenfritsme diseasespecificcomorbidityclustersincopdandacceleratedaging
AT reynaertniki diseasespecificcomorbidityclustersincopdandacceleratedaging
AT gaffronswetlana diseasespecificcomorbidityclustersincopdandacceleratedaging
AT spruitmartijna diseasespecificcomorbidityclustersincopdandacceleratedaging
AT janssendaisyja diseasespecificcomorbidityclustersincopdandacceleratedaging
AT ruttenericapa diseasespecificcomorbidityclustersincopdandacceleratedaging
AT woutersemielfm diseasespecificcomorbidityclustersincopdandacceleratedaging
AT vanfleterenlowieegw diseasespecificcomorbidityclustersincopdandacceleratedaging